Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

NIAID director Anthony Fauci testifies during a July congressional hearing on Capitol Hill. Photo: Kevin DietschI/AFP via Getty Images

NIAID director Anthony Fauci cast doubt during a National Geographic discussion due to air this week on the effectiveness of Russia's registered coronavirus vaccine touted by President Vladimir Putin on Tuesday.

Why it matters: "Having a vaccine ... and proving that a vaccine is safe and effective are two different things," Fauci told told ABC News' Deborah Roberts in the discussion, expected to air on Thursday. His comments add to the weight of skepticism from scientists around the world on the Russia vaccine. There is no published scientific to support support Putin's claims.

"I hope that the Russians have actually, definitively proven that the vaccine is safe and effective. I seriously doubt that they've done that."
— Anthony Fauci to Roberts

Of note: The World Health Organization issued a statement Tuesday noting that it is following Russia's progress in developing a COVID-19 vaccine, but cautioned that "progress in the fight against the virus should not compromise on safety."

By the numbers: More than 20.1 million people have tested positive for the novel coronavirus and over 738,700 have died from the virus worldwide from the virus, per Johns Hopkins.

Go deeper: Russia’s vaccine gamble

Go deeper

Nov 18, 2020 - Health

Pfizer says latest data shows its coronavirus vaccine is safe and 95% effective

Photo: Dogukan Keskinkilic/Anadolu Agency via Getty Images

Pfizer said on Wednesday that its coronavirus vaccine is 95% effective and has no serious side effects.

The state of play: The company said they have enough safety data now and plan to request an emergency use authorization from the Food and Drug Administration "within days."

Nov 18, 2020 - Health

Over a quarter-million people have died in the U.S. from COVID-19

Photo: Tayfun Coskun/Anadolu Agency via Getty

The United States topped 250,000 coronavirus-related deaths on Wednesday as infections soar in nearly every pocket of every state in the country, according to Johns Hopkins University data.

Why it matters: The sharp rise in the number of cases and fatalities has accelerated calls for government action. Wednesday's news exceeded infectious disease expert Anthony Fauci's March prediction in which he said "we should be prepared" that COVID-19 could kill 240,000 Americans.

Updated 12 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Annelise Capossela/Axios

  1. Health: Coronavirus cases hit a seven-month low — Majority back vaccine proof requirements for travel, schools and work — The race to avoid a possible "monster" COVID variant.
  2. Politics: Oklahoma secures $2.6 million refund for hydroxychloroquine purchase — Why Biden's latest vaccine goal is his hardest yet.
  3. Vaccines: Pfizer begins application for full FDA approval of COVID-19 vaccine — Moderna says its COVID booster shot shows promise against variants.
  4. Economy: U.S. adds just 266,000 jobs in April, far below expectations — Americans' return to the skies could benefit smaller airlines.
  5. World: WHO authorizes China's Sinopharm COVID-19 vaccine for emergency use — Mixed response in Europe to Biden's vaccine patents bombshell.
  6. Variant tracker: Where different strains are spreading.